• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Allegra-D (fexofenadine HCL /pseudoephedrinie HCL) extended release tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2010

 

Summary View

 

ADVERSE REACTIONS

Pseudoephedrine Hydrochloride
  • ischemic colitis have been reported